About Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies
Novosibirsk State Medical University is a medical university in Novosibirsk, Russia for training qualified doctors. It was organized in 1935 when the medical faculty was opened. Until 1999 it was known as the Novosibirsk medical institute. From 1999 to 2005 it is the Novosibirsk state medical academy.
Clinical Trials at Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies
During the past decade, Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 15 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 11 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies" #1 sponsor was "Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation" with 5 trials, followed by "Materia Medica Holding" with 4 trials
sponsored, "Pfizer" with 4 trials sponsored, "Galapagos NV" with 3 trials sponsored and "H. Lundbeck A/S"
with 3 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies"
#1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "I.M. Sechenov First Moscow State Medical University" with 3 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "IQVIA Pvt. Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies
According to Clinical.Site data, the most researched conditions in "Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies" are
"Ulcerative Colitis" (4 trials), "Cardiovascular Disease" (2 trials), "Crohn's Disease" (2 trials), "Depressive Disorder, Major" (2 trials) and "Obesity" (2 trials). Many other conditions were trialed in "Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies" in a lesser frequency.
Clinical Trials Intervention Types at Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies
Most popular intervention types in "Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies" are "Drug" (18 trials), "Device" (5 trials), "Other" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "ADRC isolation" (4 trials), "Filgotinib" (4 trials), "Liposuction" (4 trials) and "Arthroscopic surgery" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies
The vast majority of trials in "Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies" are
22 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies
Currently, there are NaN active trials in "Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 15 completed trials in Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies, 5 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".